An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole.
about
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal womenAromatase inhibitors for treatment of advanced breast cancer in postmenopausal womenEndocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogensCurrent medical treatment of estrogen receptor-positive breast cancerReview of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrantHypoxia-inducible factor 1 and breast cancer metastasisFACE: the barefaced facts of AI potency.The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuumProspective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.Endocrine therapy and other targeted therapies for metastatic breast cancer.The discovery and mechanism of action of letrozole.The patient experienceLetrozole in the extended adjuvant setting: MA.17A decade of letrozole: FACEAromatase inhibitors in the treatment of early and advanced breast cancer.Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents.Progress in endocrine approaches to the treatment and prevention of breast cancerExtended adjuvant therapy with letrozole: reducing the risk of recurrence.Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozoleRefining the postmenopausal breast cancer treatment paradigm: the FACE trial.Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategies.The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.Long-term safety of aromatase inhibitors in the treatment of breast cancer.Aromatase inhibitors in post-menopausal metastatic breast carcinoma.Letrozole: present and future role in the treatment of breast cancer.Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy.Update on the use of letrozole in breast cancer.Anastrozole for malignant and benign conditions: present applications and future therapeutic integrations.Economic evaluation of fulvestrant as an extra step in the treatment sequence for ER-positive advanced breast cancer.Optimal management of bone metastases in breast cancer patients.Optimal adjuvant endocrine therapy for early breast cancer.Early recurrence risk: aromatase inhibitors versus tamoxifen.Use of aromatase inhibitors and bisphosphonates as an anticancer therapy in postmenopausal breast cancer.When to start an aromatase inhibitor: now or later?Management of patients with metastatic breast cancer.Current status and future perspectives in the endocrine treatment of postmenopausal, hormone receptor-positive metastatic breast cancer.Aromatase inhibitor-induced arthralgia: a review.Effect of obesity on aromatase inhibitor efficacy in postmenopausal, hormone receptor-positive breast cancer: a systematic review.Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer.Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysis.
P2860
Q24239985-DA175EF8-0001-49D0-9C3B-DED1C582BA95Q24246391-B0EEA38C-2EAD-4091-BFE5-376934F35517Q24796233-FE6F963A-9FEA-4EBA-9B5E-047CB2945477Q26795751-8A6FA64C-22B0-4DBF-8BA8-D1BB918C0159Q28076777-3F7484BE-233E-4638-8DFE-44B96F957923Q28087393-53D86067-FDC6-480A-AFC6-5B58486B637CQ34417834-CF7E44F1-2B12-474C-9610-CB547B911F5AQ34592879-2183E2A5-3D50-4438-9ADD-465BEB79EC75Q34847405-21B13D3E-E03F-407F-BE0F-A09BD5604D43Q35987790-02329AB7-2E6E-41E4-B98E-16F1C8890495Q36026408-444E7F60-15AF-4EEC-A653-AC93A98CBE5DQ36026414-99C26BE7-2A69-4944-BAA8-0EAA6841A151Q36026553-D4144CD7-E92F-4126-9795-A5FAB3051BDCQ36026558-FFB712F0-6D94-443F-907B-1EE0DE8259DBQ36105220-40156276-DDE7-43FC-8F41-CDBF4471314BQ36297937-E5EEF883-8451-4583-9A94-792CFE429B1FQ36457511-75B0F21A-3B42-4230-A176-63F200903C70Q36500530-8BA105E7-0C58-4086-AFCD-74874B0DF1EBQ36614055-C32C867C-AA95-433C-9C7C-A74247526708Q36636623-3DC8967C-6FDC-431F-9C6E-7D10AC59CF6CQ36675384-524B4C12-03B6-43B5-AE15-EF92FA2E1813Q36817100-B0C2E959-3D84-4644-A467-4F3902B3DDE5Q36822883-144E5BED-4B1F-424C-B90D-5FAED6098CD9Q36861597-A0BE0CB3-D54A-4250-9170-7116DFC1AFAAQ36909294-2880A973-FFE0-4865-9049-6680172E4E4EQ36915182-83427588-A116-4C97-B205-7C6519AB3CF7Q36967277-118DDCAF-6B24-4CC0-AA47-EDB3EAC0CDC1Q36967279-0403E6F0-8822-495A-AA24-F2601AD23D3EQ37023877-47EC8A74-0F8B-4313-A370-8DEAF54A7FD1Q37355487-834BBAFD-5C0B-4F1B-AB50-274BA5A594B3Q37738877-2CE96672-FF3E-4F8D-8703-5740B1AC8857Q37782092-CA7BDA04-E655-43F0-A864-4AF6924A39A4Q37794991-44CAF732-7A84-4C0C-BDEF-3F063B5CF92EQ37848271-BAAE6AE0-B8B8-4CC3-A407-B5ABB945BB74Q37933166-82139AFB-D694-442E-A75B-65914D803145Q38044021-A72AEA50-FCF8-4B61-B7AC-61B7D9ADF661Q38087499-502BCF41-6E25-43C1-BB82-EE189B55A32FQ38239596-331BF037-753F-4EAE-92B5-056741CF0758Q38352305-EE907623-0625-482B-B04C-C451A287DB0EQ39277913-0B279FAB-06D6-4188-BA61-BD2FB0D9206E
P2860
An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
An open randomised trial of se ...... ors letrozole and anastrozole.
@en
An open randomised trial of se ...... ors letrozole and anastrozole.
@nl
type
label
An open randomised trial of se ...... ors letrozole and anastrozole.
@en
An open randomised trial of se ...... ors letrozole and anastrozole.
@nl
prefLabel
An open randomised trial of se ...... ors letrozole and anastrozole.
@en
An open randomised trial of se ...... ors letrozole and anastrozole.
@nl
P2093
P1476
An open randomised trial of se ...... ors letrozole and anastrozole.
@en
P2093
Ben Ayed F
Burdette-Radoux S
Caicedo JJ
Chaudri-Ross HA
Davidson N
Gershanovich M
Gervasio H
Manikhas G
P304
P356
10.1016/S0959-8049(03)00630-0
P577
2003-11-01T00:00:00Z